Zealand Pharma grants warrants to employees in Denmark

Provided By Globe Newswire

Last update: Sep 13, 2022

Company announcement – No. 40 / 2022

Zealand Pharma grants warrants to employees in Denmark

Copenhagen, DK and Boston, MA, September 13, 2022 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces granting of warrants to employees in accordance with Zealand's Remuneration policy and overall guidelines for incentive pay, as adopted at the annual general meeting held on April 6, 2022.